Sphera Funds Management Ltd. Molecular Partners Ag Call Options Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
6Shares Held
2.67MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$10.7 Million0.44% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$6.5 Million0.24% of portfolio
-
Ubs Group Ag6.87KShares$32,9850.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,7610.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,2910.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $156M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...